Genome-wide expression analysis reveals diverse effects of acute nicotine exposure on neuronal function-related genes and pathways

Frontiers in Psychiatry

Volumn 2, Issue MAR, 2011, Pages

  Wang, Ju ^a   Cui, Wenyan ^a,b   Wei, Jinxue ^a   Sun, Dongxiao ^a   Gutala, Ramana ^a   Gu, Jun ^b   Li, Ming D ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b PEKING UNIVERSITY   (China)

Author keywords

Gene expression; Mecamylamine; Neurons; Nicotine; p38

Indexed keywords

NICOTINE; NICOTINIC RECEPTOR;

ARTICLE; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; MOLECULAR PATHOLOGY; NERVE CELL; NERVOUS SYSTEM FUNCTION; SIGNAL TRANSDUCTION; TOBACCO DEPENDENCE;

EID: 84866771706     PISSN: None     EISSN: 16640640     Source Type: Journal    
DOI: 10.3389/fpsyt.2011.00005     Document Type: Article

References (115)

1. Adamopoulos, D., Argacha, J. F., Gujic, M., Preumont, N., Degaute, J. P., and van de Borne, P. (2009). Acute effects of nicotine on arterial stiffness and wave reflection in healthy young non smokers. Clin. Exp. Pharmacol. Physiol. 36, 784-789.
2. Adams, J. P., and Sweatt, J. D. (2002). Molecular psychology: roles for the ERK MAP kinase cascade in memory. Annu. Rev. Pharmacol. Toxicol. 42, 135-163.
3. Ambroggi, F., Turiault, M., Milet, A., Deroche-Gamonet, V., Parnaudeau, S., Balado, E., Barik, J., van der Veen, R., Maroteaux, G., Lemberger, T., Schutz, G., Lazar, M., Marinelli, M., Piazza, P. V., and Tronche, F. (2009). Stress and addiction: glucocorticoid receptor in dopaminoceptive neurons facilitates cocaine seeking. Nat. Neurosci. 12, 247-249.
4. Argacha, J. F., Adamopoulos, D., Gujic, M., Fontaine, D., Amyai, N., Berkenboom, G., and van de Borne, P. (2008). Acute effects of passive smoking on peripheral vascular function. Hypertension 51, 1506-1511.
5. Arrick, D. M., and Mayhan, W. G. (2007). Acute infusion of nicotine impairs nNOS-dependent reactivity of cerebral arterioles via an increase in oxidative stress. J. Appl. Physiol. 103, 2062-2067.
6. Barik, J., and Wonnacott, S. (2006). Indirect modulation by alpha7 nicotinic acetylcholine receptors of noradrenaline release in rat hippocampal slices: interaction with glutamate and GABA systems and effect of nicotine withdrawal. Mol. Pharmacol. 69, 618-628.
7. Barik, J., and Wonnacott, S. (2009). Molecular and cellular mechanisms of action of nicotine in the CNS. Handb. Exp. Pharmacol. 173-207.
8. Benjamini, Y., and Hochberg, Y. (1995). Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Series B 57, 289-300.
9. Benwell, M. E., and Balfour, D. J. (1992). The effects of acute and repeated nicotine treatment on nucleus accumbens dopamine and locomotor activity. Br. J. Pharmacol. 105, 849-856.
10. Benwell, M. E., and Balfour, D. J. (1997). Regional variation in the effects of nicotine on catecholamine overflow in rat brain. Eur. J. Pharmacol. 325, 13-20.
11. Bierut, L. J., Madden, P. A., Breslau, N., Johnson, E. O., Hatsukami, D., Pomerleau, O. F., Swan, G. E., Rutter, J., Bertelsen, S., Fox, L., Fugman, D., Goate, A. M., Hinrichs, A. L., Konvicka, K., Martin, N. G., Montgomery, G. W.,Saccone, N. L., Saccone, S. F., Wang, J. C., Chase, G. A., Rice, J. P., and Ballinger, D. G. (2007). Novel genes identified in a high-density genome wide association study for nicotine dependence. Hum. Mol. Genet. 16, 24-35.
12. Bonsch, D., Lederer, T., Reulbach, U., Hothorn, T., Kornhuber, J., and Bleich, S. (2005). Joint analysis of the NACP-REP1 marker within the alpha synuclein gene concludes association with alcohol dependence. Hum. Mol. Genet. 14, 967-971.
13. Brunzell, D. H., Russell, D. S., and Picciotto, M. R. (2003) In vivo nicotine treatment regulates mesocorticolimbic CREB and ERK signaling in C57Bl/6J mice. J. Neurochem. 84, 1431-1441.
14. Caggiula, A. R., Donny, E. C., Epstein, L. H., Sved, A. F., Knopf, S., Rose, C., McAllister, C. G., Antelman, S. M., and Perkins, K. A. (1998). The role of corticosteroids in nicotine's physiological and behavioral effects. Psychoneuroendocrinology 23, 143-159.
15. Cao, J., Dwyer, J. B., Mangold, J. E., Wang, J., Wei, J., Leslie, F. M., and Li, M. D. (2011). Modulation of cell adhesion systems by prenatal nicotine exposure in limbic brain regions of adolescent female rats. Int. J. Neuropsychopharmacol. 14, 157-174.
16. Chang, L., Rapoport, S. I., Nguyen, H. N., Greenstein, D., Chen, M., and Basselin, M. (2009). Acute nicotine reduces brain arachidonic acid signaling in unanesthetized rats. J. Cereb. Blood Flow Metab. 29, 648-658.
17. Chavez-Noriega, L. E., Crona, J. H., Washburn, M. S., Urrutia, A., Elliott, K. J., and Johnson, E. C. (1997). Pharmacological characterization of recombinant human neuronal nicotinic acetylcholine receptors h alpha 2 beta 2, h alpha 2 beta 4, h alpha 3 beta 2, h alpha 3 beta 4, h alpha 4 beta 2, h alpha 4 beta 4 and h alpha 7 expressed in Xenopus oocytes. J. Pharmacol. Exp. Ther. 280, 346-356.
18. Chen, M., Wang, T., Liao, Z. X., Pan, X. L., Feng, Y. H., and Wang, H. (2007). Nicotine-induced prenatal overexposure to maternal glucocorticoid and intrauterine growth retardation in rat. Exp. Toxicol. Pathol. 59, 245-251.
19. Clark, A. R., and Lasa, M. (2003). Crosstalk between glucocorticoids and mitogen-activated protein kinase signalling pathways. Curr. Opin. Pharmacol. 3, 404-411.
20. Cole, T. J., Blendy, J. A., Monaghan, A. P., Krieglstein, K., Schmid, W., Aguzzi, A., Fantuzzi, G., Hummler, E., Unsicker, K., and Schutz, G. (1995). Targeted disruption of the glucocorticoid receptorgene blocks adrenergic chromaffin cell development and severely retards lung maturation. Genes Dev. 9, 1608-1621.
21. Cormier, A., Morin, C., Zini, R., Tillement, J. P., and Lagrue, G. (2001) In vitro effects of nicotine on mitochondrial respiration and superoxide anion generation. Brain Res. 900, 72-79.
22. Cucina, A., Corvino, V., Sapienza, P., Borrelli, V., Lucarelli, M., Scarpa, S., Strom, R., Santoro-D'Angelo, L., and Cavallaro, A. (1999). Nicotine regulates basic fibroblastic growth factor and transforming growth factor beta1 production in endothelial cells. Biochem. Biophys. Res. Commun. 257, 306-312.
23. Dajas-Bailador, F., and Wonnacott, S. (2004). Nicotinic acetylcholine receptors and the regulation of neuronal signalling. Trends Pharmacol. Sci. 25, 317-324.
24. Dajas-Bailador, F. A., Soliakov, L., and Wonnacott, S. (2002). Nicotine activates the extracellular signal-regulated kinase 1/2 via the alpha7 nicotinic acetylcholine receptor and protein kinase A, in SH-SY5Y cells and hippocampal neurones. J. Neurochem. 80, 520-530.
25. Dasgupta, P., and Chellappan, S. P. (2006). Nicotine-mediated cell proliferation and angiogenesis: new twists to an old story. Cell Cycle 5, 2324-2328.
26. Dasgupta, P., Rastogi, S., Pillai, S., Ordonez-Ercan, D., Morris, M., Haura, E., and Chellappan, S. (2006). Nicotine induces cell proliferation by beta-arrestin-mediated activation of Src and Rb-Raf-1 pathways. J. Clin. Invest. 116, 2208-2217.
27. Dittmar, K. D., Banach, M., Galigniana, M. D., and Pratt, W. B. (1998). The role of DnaJ-like proteins in glucocorticoid receptor.hsp90 heterocomplex assembly by the reconstituted hsp90. p60.hsp70 foldosome complex. J. Biol. Chem. 273, 7358-7366.
28. Dittmar, K. D., Demady, D. R., Stancato, L. F., Krishna, P., and Pratt, W. B. (1997). Folding of the glucocorticoid receptor by the heat shock protein (hsp) 90-based chaperone machinery. The role of p23 is to stabilize receptor. hsp90 heterocomplexes formed by hsp90.p60.hsp70. J. Biol. Chem. 272, 21213-21220.
29. Dunckley, T., and Lukas, R. J. (2003). Nicotine modulates the expression of a diverse set of genes in the neuronal SH-SY5Y cell line. J. Biol. Chem. 278, 15633-15640.
30. Dunckley, T., and Lukas, R. J. (2006). Nicotinic modulation of gene expression in SH-SY5Y neuroblastoma cells. Brain Res. 1116, 39-49.
31. Edwards, S., Graham, D. L., Bachtell, R. K., and Self, D. W. (2007). Region-specific tolerance to cocaine-regulated cAMP-dependent protein phosphorylation following chronic self-administration. Eur. J. Neurosci. 25, 2201-2213.
32. Ernst, M., Heishman, S. J., Spurgeon, L., and London, E. D. (2001). Smoking history and nicotine effects on cognitive performance. Neuropsychopharmacology 25, 313-319.
33. Ficklin, M. B., Zhao, S., and Feng, G. (2005). Ubiquilin-1 regulates nicotine-induced up-regulation of neuronal nicotinic acetylcholine receptors. J. Biol. Chem. 280, 34088-34095.
34. Foulds, J., Stapleton, J., Swettenham, J., Bell, N., McSorley, K., and Russell, M. A. (1996). Cognitive performance effects of subcutaneous nicotine in smokers and never-smokers. Psychopharmacology (Berl.) 127, 31-38.
35. Fox, H. C., Jackson, E. D., and Sinha, R. (2009). Elevated cortisol and learning and memory deficits in cocaine dependent individuals: relationship to relapse outcomes. Psychoneuroendocrinology 34, 1198-1207.
36. French, K. L., Granholm, A. C., Moore, A. B., Nelson, M. E., and Bimonte-Nelson, H. A. (2006). Chronic nicotine improves working and reference memory performance and reduces hippocampal NGF in aged female rats. Behav. Brain Res. 169, 256-262.
37. Gaddnas, H., Pietila, K., Piepponen, T. P., and Ahtee, L. (2001). Enhanced motor activity and brain dopamine turnover in mice during long-term nicotine administration in the drinking water. Pharmacol. Biochem. Behav. 70, 497-503.
38. Garrido, R., King-Pospisil, K., Son, K. W., Hennig, B., and Toborek, M. (2003). Nicotine upregulates nerve growth factor expression and prevents apoptosis of cultured spinal cord neurons. Neurosci. Res. 47, 349-355.
39. Gaudilliere, B., Shi, Y., and Bonni, A. (2002). RNA interference reveals a requirement for myocyte enhancer factor 2A in activity-dependent neuronal survival. J. Biol. Chem. 277, 46442-46446.
40. Ghosh, J., Murphy, M. O., Turner, N., Khwaja, N., Halka, A., Kielty, C. M., and Walker, M. G. (2005). The role of transforming growth factor beta1 in the vascular system. Cardiovasc. Pathol. 14, 28-36.
41. Gould, J., Reeve, H. L., Vaughan, P. F., and Peers, C. (1992). Nicotinic acetylcholine receptors in human neuroblastoma (SH-SY5Y) cells. Neurosci. Lett. 145, 201-204.
42. Grenhoff, J., and Svensson, T. H. (1988). Selective stimulation of limbic dopamine activity by nicotine. Acta Physiol. Scand. 133, 595-596.
43. Gueorguiev, V. D., Cheng, S. Y., and Sabban, E. L. (2006). Prolonged activation of cAMP-response element-binding protein and ATF-2 needed for nicotine-triggered elevation of tyrosine hydroxylase gene transcription in PC12 cells. J. Biol. Chem. 281, 10188-10195.
44. Gupta, V., Awasthi, N., and Wagner, B. J. (2007). Specific activation of the glucocorticoid receptor and modulation of signal transduction pathways in human lens epithelial cells. Invest. Ophthalmol. Vis. Sci. 48, 1724-1734.
45. Gutala, R., Wang, J., Kadapakkam, S., Hwang, Y., Ticku, M., and Li, M. D. (2004). Microarray analysis of ethanol-treated cortical neurons reveals disruption of genes related to the ubiquitin-proteasome pathway and protein synthesis. Alcohol. Clin. Exp. Res. 28, 1779-1788.
46. Harkness, P. C., and Millar, N. S. (2002). Changes in conformation and subcellular distribution of alpha4beta2 nicotinic acetylcholine receptors revealed by chronic nicotine treatment and expression of subunit chimeras. J. Neurosci. 22, 10172-10181.
47. Heidenreich, K. A., and Linseman, D. A. (2004). Myocyte enhancer factor-2 transcription factors in neuronal differentiation and survival. Mol. Neurobiol. 29, 155-166.
48. Hernandez, C. M., and Terry, A. V. Jr. (2005). Repeated nicotine exposure in rats: effects on memory function, cholinergic markers and nerve growth factor. Neuroscience 130, 997-1012.
49. Heusch, W. L., and Maneckjee, R. (1998). Signalling pathways involved in nicotine regulation of apoptosis of human lung cancer cells. Carcinogenesis 19, 551-556.
50. Hwang, Y. Y., and Li, M. D. (2006). Proteins differentially expressed in response to nicotine in five rat brain regions: identification using a 2-DE/ MS-based proteomics approach. Proteomics 6, 3138-3153.
51. Ichino, N., Ishiguro, H., Yamada, K., Nishii, K., Sawada, H., and Nagatsu, T. (1999). Nicotine withdrawal up-regulates c-Fos transcription in pheochromocytoma cells. Neurosci. Res. 35, 63-69.
52. Ichino, N., Yamada, K., Nishii, K., Sawada, H., Nagatsu, T., and Ishiguro, H. (2002). Increase of transcriptional levels of egr-1 and nur77 genes due to both nicotine treatment and withdrawal in pheochromocytoma cells. J. Neural Transm. 109, 1015-1022.
53. Isola, R., Zhang, H., Tejwani, G. A., Neff, N. H., and Hadjiconstantinou, M. (2009). Acute nicotine changes dynorphin and prodynorphin mRNA in thestriatum. Psychopharmacology (Berl.) 201, 507-516.
54. Jiao, H., Zhang, L., Gao, F., Lou, D., Zhang, J., and Xu, M. (2007). Dopamine D(1) and D(3) receptors oppositely regulate NMDA- and cocaine-induced MAPK signaling via NMDA receptor phosphorylation. J. Neurochem. 103, 840-848.
55. Jonnala, R. R., Terry, A. V. Jr., and Buccafusco, J. J. (2002). Nicotine increases the expression of high affinity nerve growth factor receptors in both in vitro and in vivo. Life Sci. 70, 1543-1554.
56. Kane, J. K., Konu, O., Ma, J. Z., and Li, M. D. (2004). Nicotine coregulates multiple pathways involved in protein modification/degradation in rat brain. Brain Res. Mol. Brain Res. 132, 181-191.
57. Katyare, S. S., and Shallom, J. M. (1988). Altered cerebral protein turnover in rats following prolonged in vivo treatment with nicotine. J. Neurochem. 50, 1356-1363.
58. Ke, L., Eisenhour, C. M., Bencherif, M., and Lukas, R. J. (1998). Effects of chronic nicotine treatment on expression of diverse nicotinic acetylcholine receptor subtypes. I. Dose- and time-dependent effects of nicotine treatment. J. Pharmacol. Exp. Ther. 286, 825-840.
59. Kenny, P. J., File, S. E., and Rattray, M. (2001). Nicotine regulates 5-HT(1A) receptor gene expression in the cerebral cortex and dorsal hippocampus. Eur. J. Neurosci. 13, 1267-1271.
60. Kobayashi, H., Ide, S., Hasegawa, J., Ujike, H., Sekine, Y., Ozaki, N., Inada, T., Harano, M., Komiyama, T., Yamada, M., Iyo, M., Shen, H. W., Ikeda, K., and Sora, I. (2004). Study of association between alpha-synuclein gene polymorphism and methamphetamine psychosis/dependence. Ann. N. Y. Acad. Sci. 1025, 325-334.
61. Konu, O., Kane, J. K., Barrett, T., Vawter, M. P., Chang, R., Ma, J. Z., Donovan, D. M., Sharp, B., Becker, K. G., and Li, M. D. (2001). Region-specific transcriptional response to chronic nicotine in rat brain. Brain Res. 909, 194-203.
62. Konu, O., Xu, X., Ma, J. Z., Kane, J., Wang, J., Shi, S. J., and Li, M. D. (2004a). Application of a customized pathway-focused microarray for gene expression profiling of cellular homeostasis upon exposure to nicotine in PC12 cells. Brain Res. Mol. Brain Res. 121, 102-113.
63. Konu, O., Xu, X., Ma, J. Z., Kane, J. K., Wang, J., Shi, S. J., and Li, M. D. (2004b). Application of a customized pathway-focused microarray for gene expression profiling of cellular homeostasis upon exposure to nicotine inPC12 cells. Brain Res. Mol. Brain Res. 110, 102-113.
64. Kumari, V., Gray, J. A., Ffytche, D. H., Mitterschiffthaler, M. T., Das, M., Zachariah, E., Vythelingum, G. N., Williams, S. C., Simmons, A., and Sharma, T. (2003). Cognitive effects of nicotine in humans: an fMRI study. Neuroimage 19, 1002-1013.
65. Lane, D., Gray, E. A., Mathur, R. S., and Mathur, S. P. (2005). Up-regulation of vascular endothelial growth factor-C by nicotine in cervical cancer cell lines. Am. J. Reprod. Immunol. 53, 153-158.
66. Levi-Montalcini, R. (1987). The nerve growth factor 35 years later. Science 237, 1154-1162.
67. Levin, E. D., and Rose, J. E. (1995). Acute and chronic nicotinic interactions with dopamine systems and working memory performance. Ann. N. Y. Acad. Sci. 757, 245-252.
68. Levin, E. D., and Simon, B. B. (1998). Nicotinic acetylcholine involvement in cognitive function in animals. Psychopharmacology (Berl.) 138, 217-230.
69. Li, M., Linseman, D. A., Allen, M. P., Meintzer, M. K., Wang, X., Laessig, T., Wierman, M. E., and Heidenreich, K. A. (2001). Myocyte enhancer factor 2A and 2D undergo phosphorylation and caspase-mediated degradation during apoptosis of rat cerebellar granule neurons. J. Neurosci. 21, 6544-6552.
70. Li, M. D., Kane, J. K., Wang, J., and Ma, J. Z. (2004). Time-dependent changes in transcriptional profiles within five rat brain regions in response to nicotine treatment. Brain Res. Mol. Brain Res. 132, 168-180.
71. Mao, Z., Bonni, A., Xia, F., Nadal-Vicens, M., and Greenberg, M. E. (1999). Neuronal activity-dependent cell survival mediated by transcription factor MEF2. Science 286, 785-790.
72. Marinelli, M., and Piazza, P. V. (2002). Interaction between glucocorticoid hormones, stress and psychostimulant drugs. Eur. J. Neurosci. 16, 387-394.
73. Mash, D. C., Adi, N., Duque, L., Pablo, J., Kumar, M., and Ervin, F. R. (2008). Alpha synuclein protein levels are increased in serum from recently abstinent cocaine abusers. Drug Alcohol Depend. 94, 246-250.
74. Mexal, S., Frank, M., Berger, R., Adams, C. E., Ross, R. G., Freedman, R., and Leonard, S. (2005). Differential modulation of gene expression in the NMDA postsynaptic density of schizophrenic and control smokers. Brain Res. Mol. Brain Res. 139, 317-332.
75. Nakayama, H., Numakawa, T., Ikeuchi, T., and Hatanaka, H. (2001). Nicotine-induced phosphorylation of extracellular signal-regulated proteinkinase and CREB in PC12h cells. J. Neurochem. 79, 489-498.
76. Nisell, M., Nomikos, G. G., Chergui, K., Grillner, P., and Svensson, T. H. (1997). Chronic nicotine enhances basal and nicotine-induced Fos immunoreactivity preferentially in the medial prefrontal cortex of the rat. Neuropsychopharmacology 17, 151-161.
77. Novak, G., Boukhadra, J., Shaikh, S. A., Kennedy, J. L., and Le Foll, B. (2009). Association of a polymorphism in the NRXN3 gene with the degree of smoking in schizophrenia: a preliminary study. World J. Biol. Psychiatry 10, 929-935.
78. Nussbaum, J., Xu, Q., Payne, T. J., Ma, J. Z., Huang, W., Gelernter, J., and Li, M. D. (2008). Significant association of the neurexin-1 gene (NRXN1) with nicotine dependence in European-and African-American smokers. Hum. Mol. Genet. 17, 1569-1577.
79. Onal, A., Uysal, A., Ulker, S., Delen, Y., Yurtseven, M. E., and Evinc, A. (2004). Alterations of brain tissue in fetal rats exposed to nicotine in utero: possible involvement of nitric oxide and catecholamines. Neurotoxicol. Teratol. 26, 103-112.
80. Pagliusi, S. R., Tessari, M., DeVevey, S., Chiamulera, C., and Pich, E. M. (1996). The reinforcing properties of nicotine are associated with a specific patterning of c-fos expression in the rat brain. Eur. J. Neurosci. 8, 2247-2256.
81. Papke, R. L., Sanberg, P. R., and Shytle, R. D. (2001). Analysis of mecamylamine stereoisomers on human nicotinic receptor subtypes. J. Pharmacol. Exp. Ther. 297, 646-656.
82. Peng, X., Katz, M., Gerzanich, V., Anand, R., and Lindstrom, J. (1994). Human alpha 7 acetylcholine receptor: cloning of the alpha 7 subunit from the SH-SY5Y cell line and determination of pharmacological properties of native receptors and functional alpha 7 homomers expressed in Xenopus oocytes. Mol. Pharmacol. 45, 546-554.
83. Phillips, S., and Fox, P. (1998). An investigation into the effects of nicotine gum on short-term memory. Psychopharmacology (Berl.) 140, 429-433.
84. Piazza, P. V., and Le Moal, M. (1997). Glucocorticoids as a biological substrate of reward: physiological and pathophysiological implications. Brain Res. Brain Res. Rev. 25, 359-372.
85. Pollman, M. J., Naumovski, L., and Gibbons, G. H. (1999). Vascular cell apoptosis: cell type-specific modulation by transforming growth factor-beta1 in endothelial cells versus smooth muscle cells. Circulation 99, 2019-2026.
86. Reuter, M., Hennig, J., and Netter, P. (2004). Do smoking intensity-related differences in vigilance indicate altered glucocorticoid receptor sensitivity? Addict. Biol. 9, 35-41.
87. Rezvani, K., Teng, Y., Shim, D., and De Biasi, M. (2007). Nicotine regulates multiple synaptic proteins by inhibiting proteasomal activity. J. Neurosci. 27, 10508-10519.
88. Robinson, T. E., and Kolb, B. (2004). Structural plasticity associated with exposure to drugs of abuse. Neuropharmacology 47(Suppl. 1), 33-46.
89. Robinson-Rechavi, M., Carpentier, A. S., Duffraisse, M., and Laudet, V. (2001). How many nuclear hormone receptors are there in the human genome? Trends Genet. 17, 554-556.
90. Salminen, O., Seppa, T., Gaddnas, H., and Ahtee, L. (1999). The effects of acute nicotine on the metabolism of dopamine and the expression of Fos protein in striatal and limbic brain areas of rats during chronic nicotine infusion and its withdrawal. J. Neurosci. 19, 8145-8151.
91. Schmitt, H. F., Huang, L. Z., Son, J. H., Pinzon-Guzman, C., Slaton, G. S., and Winzer-Serhan, U. H. (2008). Acute nicotine activates c-fos and activity-regulated cytoskeletal associated protein mRNA expression in limbic brain areas involved in the central stress-response in rat pups during a period of hypo-responsiveness to stress. Neuroscience 157, 349-359.
92. Schochet, T. L., Bremer, Q. Z., Brownfield, M. S., Kelley, A. E., and Landry, C. F. (2008). The dendritically targeted protein dendrin is induced by acute nicotine in cortical regions of adolescent rat brain. Eur. J. Neurosci. 28, 1967-1979.
93. Schochet, T. L., Kelley, A. E., and Landry, C. F. (2004). Differential behavioral effects of nicotine exposure in adolescent and adult rats. Psychopharmacology (Berl.) 175, 265-273.
94. Schochet, T. L., Kelley, A. E., and Landry, C. F. (2005). Differential expression of arc mRNA and other plasticity-related genes induced by nicotine in adolescent rat forebrain. Neuroscience 135, 285-297.
95. Shalizi, A. K., and Bonni, A. (2005). brawn for brains: the role of MEF2 proteins in the developing nervous system. Curr. Top. Dev. Biol. 69, 239-266.
96. Soderstrom, K., Qin, W., Williams, H., Taylor, D. A., and McMillen, B. A. (2007). Nicotine increases FosB expression within a subset of reward- and memory-related brain regions during both peri- and post-adolescence. Psychopharmacology (Berl.) 191, 891-897.
97. Soto-Otero, R., Mendez-Alvarez, E., Hermida-Ameijeiras, A., Lopez-Real, A. M., and Labandeira-Garcia, J. L. (2002). Effects of (-)-nicotine and (-)-cotinine on 6-hydroxydopamine-induced oxidative stress and neurotoxicity: relevance for Parkinson's disease. Biochem. Pharmacol. 64, 125-135.
98. Spence, J. P., Liang, T., Liu, L., Johnson, P. L., Foroud, T., Carr, L. G., and Shekhar, A. (2009). From QTL to candidate gene: a genetic approach to alcoholism research. Curr. Drug Abuse Rev. 2, 127-134.
99. Suarez, S. V., Amadon, A., Giacomini, E., Wiklund, A., Changeux, J. P., Le Bihan, D., and Granon, S. (2009). Brain activation by short-term nicotine exposure in anesthetized wild-type and beta2-nicotinic receptors knockout mice: a BOLD fMRI study. Psychopharmacology (Berl.) 202, 599-610.
100. Tammimaki, A., Pietila, K., Raattamaa, H., and Ahtee, L. (2006). Effect of quinpirole on striatal dopamine release and locomotor activity in nicotine-treated mice. Eur. J. Pharmacol. 531, 118-125.
101. Tang, K., Wu, H., Mahata, S. K., and O'Connor, D. T. (1998). A crucial role for the mitogen-activated protein kinase pathway in nicotinic cholinergic signaling to secretory protein transcription in pheochromocytoma cells. Mol. Pharmacol. 54, 59-69.
102. Terry, A. V. Jr., and Clarke, M. S. (1994). Nicotine stimulation of nerve growth factor receptor expression. Life Sci. 55, PL91-PL98.
103. Thoenen, H., Bandtlow, C., and Heumann, R. (1987). The physiological function of nerve growth factor in the central nervous system: comparisonwith peiphery. Rev. Physiol. Biochem. Pharmacol. 109, 145-178.
104. Thomas, L., Welsh, L., Galvez, F., and Svoboda, K. (2008). Acute nicotine exposure and modulation of a spinal motor circuit in embryonic zebrafish. Toxicol. Appl. Pharmacol. 239, 1-12.
105. Tizabi, Y., Getachew, B., Rezvani, A. H., Hauser, S. R., and Overstreet, D. H. (2009). Antidepressant-like effects of nicotine and reduced nicotinic receptor binding in the Fawn-Hooded rat, an animal model of co-morbid depression and alcoholism. Prog. Neuropsychopharmacol. Biol. Psychiatry 33, 398-402.
106. Tye, S. J., Miller, A. D., and Blaha, C. D. (2009). Differential corticosteroid receptor regulation of mesoaccumbens dopamine efflux during the peak and nadir of the circadian rhythm: a molecular equilibrium in the midbrain? Synapse 63, 982-990.
107. Vadasz, C., Saito, M., O'Brien, D., Zavadil, J., Morahan, G., Chakraborty, G., and Wang, R. (2007). Ventral tegmental transcriptome response to intermittent nicotine treatment and withdrawal in BALB/cJ, C57BL/6ByJ, and quasi-congenic RQI mice. Neurochem. Res. 32, 457-480.
108. Wang, J., Chen, Y. B., Zhu, X. N., and Chen, R. Z. (2001). Activation of p42/44 mitogen-activated protein kinase pathway in long-term potentiation induced by nicotine in hippocampal CA1 region in rats. Acta Pharmacol. Sin. 22, 685-690.
109. Wang, J., Gutala, R., Sun, D., Ma, J. Z., Sheela, R. C., Ticku, M. K., and Li, M. D. (2007). Regulation of platelet-derived growth factor signaling pathway by ethanol, nicotine, or both in mouse cortical neurons. Alcohol. Clin. Exp. Res. 31, 357-375.
110. Wang, J., Kim, J. M., Donovan, D. M., Becker, K. G., and Li, M. D. (2009). Significant modulation of mitochondrial electron transport system by nicotine in various rat brain regions. Mitochondrion 9, 186-195.
111. Weber, R. J., Gomez-Flores, R., Smith, J. E., and Martin, T. J. (2009). Neuronal adaptations, neuroendocrine and immune correlates of heroin self-administration. Brain Behav. Immun. 23, 993-1002.
112. Wei, J., Wang, J., Dwyer, J. B., Mangold, J., Cao, J., Leslie, F. M., and Li, M. D. (2011). Gestational nicotine treatment modulates cell death/ survival-related pathways in the brains of adolescent female rats. Int. J. Neuropsychopharmacol. 14, 91-106.
113. Winer, J., Jung, C. K., Shackel, I., and Williams, P. M. (1999). Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal. Biochem. 270, 41-49.
114. Xie, Y. X., Bezard, E., and Zhao, B. L. (2005). Investigating the receptor-independent neuroprotective mechanisms of nicotine in mitochondria. J. Biol. Chem. 280, 32405-32412.
115. Yang, Y. H., Dudoit, S., Luu, P., Lin, D. M., Peng, V., Ngai, J., and Speed, T. P. (2002). Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res. 30, e15.